Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yvette N. Lamb
Observed names:
Lamb, Yvette,
Lamb, Yvette N,
Lamb, Yvette N.,
Y.N. Lamb
Institution:
Springer Nature (New Zealand)
Observed institutions:
University of Auckland,
Springer Nature (New Zealand)
OpenAlex ID:
A5047338174
BNT162b2 mRNA COVID-19 Vaccine: First Approval
2021
·
Yvette N. Lamb
·
Drugs
·
443
PDF
Inclisiran: First Approval
2021
·
Yvette N. Lamb
·
Drugs
·
391
PDF
Nirmatrelvir Plus Ritonavir: First Approval
2022
·
Yvette N. Lamb
·
Drugs
·
328
PDF
Remdesivir: First Approval
2020
·
Yvette N. Lamb
·
Drugs
·
288
PDF
Pexidartinib: First Approval
2019
·
Yvette N. Lamb
·
Drugs
·
251
PDF
Pitolisant: A Review in Narcolepsy with or without Cataplexy
2020
·
Yvette N. Lamb
·
CNS Drugs
·
218
Epi proColon® 2.0 CE: A Blood-Based Screening Test for Colorectal Cancer
2017
·
Yvette N. Lamb
, Sohita Dhillon
·
Molecular Diagnosis & Therapy
·
207
Inotuzumab Ozogamicin: First Global Approval
2017
·
Yvette N. Lamb
·
Drugs
·
203
Nintedanib: A Review in Fibrotic Interstitial Lung Diseases
2021
·
Yvette N. Lamb
·
Drugs
·
173
PDF
Ocrelizumab: A Review in Multiple Sclerosis
2022
·
Yvette N. Lamb
·
Drugs
·
150
PDF
Burosumab: First Global Approval
2018
·
Yvette N. Lamb
·
Drugs
·
119
Ozanimod: First Approval
2020
·
Yvette N. Lamb
·
Drugs
·
115
Elagolix: First Global Approval
2018
·
Yvette N. Lamb
·
Drugs
·
105
PDF
Glecaprevir/Pibrentasvir: First Global Approval
2017
·
Yvette N. Lamb
·
Drugs
·
100
Sarilumab: A Review in Moderate to Severe Rheumatoid Arthritis
2018
·
Yvette N. Lamb
, Emma D. Deeks
·
Drugs
·
99
Rosuvastatin/Ezetimibe: A Review in Hypercholesterolemia
2020
·
Yvette N. Lamb
·
American Journal of Cardiovascular Drugs
·
94
Cenegermin: A Review in Neurotrophic Keratitis
2020
·
Emma D. Deeks
, Yvette N. Lamb
·
Drugs
·
86
Givinostat: First Approval
2024
·
Yvette N. Lamb
·
Drugs
·
85
Pacritinib: First Approval
2022
·
Yvette N. Lamb
·
Drugs
·
80
Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma
2017
·
Yvette N. Lamb
, Lesley J. Scott
·
Drugs
·
77
Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLC
2021
·
Yvette N. Lamb
·
Targeted Oncology
·
75
PDF
Lasmiditan: First Approval
2019
·
Yvette N. Lamb
·
Drugs
·
69
Tafamidis: A Review in Transthyretin Amyloidosis with Polyneuropathy
2019
·
Yvette N. Lamb
, Emma D. Deeks
·
Drugs
·
64
Ganaxolone: First Approval
2022
·
Yvette N. Lamb
·
Drugs
·
62
Galcanezumab: First Global Approval
2018
·
Yvette N. Lamb
·
Drugs
·
55
Show more works
View as search
Works count:
139
Citation count:
4,708
H-index:
33
I10-index:
52
Year
Topic
Type
